APA (7th ed.) Citation

F, T., A, O. S., A, A., D, R. D., D, P., D, V., . . . SG, T. (2021). SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants. PLoS medicine, 18(7), e1003656. https://doi.org/10.1371/journal.pmed.1003656

Chicago Style (17th ed.) Citation

F, Tea, et al. "SARS-CoV-2 Neutralizing Antibodies: Longevity, Breadth, and Evasion by Emerging Viral Variants." PLoS Medicine 18, no. 7 (2021): e1003656. https://doi.org/10.1371/journal.pmed.1003656.

MLA (9th ed.) Citation

F, Tea, et al. "SARS-CoV-2 Neutralizing Antibodies: Longevity, Breadth, and Evasion by Emerging Viral Variants." PLoS Medicine, vol. 18, no. 7, 2021, p. e1003656, https://doi.org/10.1371/journal.pmed.1003656.